Filing Details
- Accession Number:
- 0001415889-24-017877
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-21 19:17:18
- Reporting Period:
- 2024-06-21
- Accepted Time:
- 2024-06-21 19:17:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1845337 | Day One Biopharmaceuticals Inc. | DAWN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1547959 | Saira Ramasastry | 2000 Sierra Point Parkway, Suite 501 Brisbane CA 94005 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-21 | 10,000 | $13.19 | 40,485 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.91 to $13.545 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.